KIYOHIDE FUJIMOTO

Professor and Chair

Nara Medical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kiyohide Fujimoto is a Professor and Chair at Nara Medical University, Japan. His research primarily focuses on urothelial cancer, renal cell carcinoma, and the implications of microbiota in muscle mass loss. Recent articles authored by Dr. Fujimoto explore innovative approaches to cancer treatment, including the use of sodium-glucose cotransporter-2 inhibitors and the effects of 5-aminolevulinic acid on radioresistance in prostate cancer.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Atsushi Mizokami

Professor

Kanazawa University

JAPAN

View details

Takashi Kobayashi

JAPAN

View details

Ujjal Kumar Bhawal

JAPAN

View details

Keita Nakane

Associate Professor

Gifu University Graduate School of Medicine

JAPAN

View details

Yasuhito Tanaka

Professor and Chair

Nara Medical University

JAPAN

View details

Yasushi Nakai

Nara Medical University

JAPAN

View details

Junichi Inokuchi

Professor

Graduate School of Medicine, University of the Ryukyus

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

KIYOHIDE FUJIMOTO

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Post-Transurethral Resection of Bladder Tumor Infection and Prognosis

5-Aminolevulinic Acid: A Novel Approach to Improving Radioresistance in Prostate Cancer

Immunosuppressant-Induced Alteration of Gut Microbiota Causes Loss of Skeletal Muscle Mass: Evidence from Animal Experiments Using Mice and Observational Study on Humans

A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial

Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors

The Circadian Rhythm of Intracellular Protoporphyrin IX Accumulation Through Heme Synthesis Pathway in Bladder Urothelial Cancer Cells Exposed to 5-Aminolevulinic Acid

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study

Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer

5-Aminolevrinic Acid Exhibits Dual Effects on Stemness in Human Sarcoma Cell Lines under Dark Conditions

Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG

ERVK13-1/miR-873-5p/GNMT Axis Promotes Metastatic Potential in Human Bladder Cancer though Sarcosine Production

Overexpression of MicroRNA-138 Affects the Proliferation and Invasion of Urothelial Carcinoma Cells by Suppressing SOX9 Expression

Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study

Hypomethylation of <i>CLDN4</i> Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer

Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies

Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method

Reply to “Predictors of Recurrence for T3a RCC: A Recurring Conundrum”

Role of Nuclear Claudin-4 in Renal Cell Carcinoma

Collaborators (7)

Atsushi Mizokami

Takashi Kobayashi

Ujjal Kumar Bhawal

Keita Nakane

Yasuhito Tanaka

Yasushi Nakai

Junichi Inokuchi

Make your next move.